Together Pharma Ltd (TLV:TGTR)
301.10
-1.00 (-0.33%)
Mar 13, 2026, 12:15 PM IDT
Together Pharma Market Cap
Together Pharma has a market cap or net worth of 52.23 million as of March 13, 2026. Its market cap has decreased by -7.87% in one year.
Market Cap
52.23M
Enterprise Value
95.33M
Revenue
109.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
301.10
Market Cap Chart
Since September 24, 2012, Together Pharma's market cap has increased from 40.78M to 52.23M, an increase of 28.10%. That is a compound annual growth rate of 1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 52.23M | -10.09% |
| Dec 31, 2025 | 58.09M | 7.36% |
| Dec 31, 2024 | 54.11M | 58.74% |
| Dec 31, 2023 | 34.09M | 82.59% |
| Dec 29, 2022 | 18.67M | -72.51% |
| Dec 30, 2021 | 67.91M | -50.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 106.89B |
| Danel (Adir Yeoshua) | 2.60B |
| BrainsWay | 1.64B |
| Kamada | 1.58B |
| Nissan Medical Industries | 84.47M |
| Clal Biotechnology Industries | 44.86M |
| Almeda Ventures Limited Partnership | 42.63M |
| BioLineRx | 39.16M |